Loading...
DirectorFull-time
Salary Range
$102,000 - $138,000 /year
This salary is estimated based on similar roles. The actual salary may vary.
About the Role
The Search and Evaluation (S&E) group supports global Business Development goals by executing strategic opportunities for research collaborations, licensing, investments, and acquisitions. As a Director of S&E Project Management, you will ensure seamless cross-functional execution of Therapeutic Area (TA) aligned strategies.
Key Responsibilities
- →Support the Search and Evaluation lead for all active diligences
- →Coordinate activities and deliverables as a core member of the S&E team
- →Contribute to cross-functional discussions from both program management and strategic perspectives
- →Lead and coordinate cross-functional diligences with external partners and internal experts
- →Identify, communicate, and manage risks across the deal portfolio
- →Drive cross-functional alignment and structure discussions for effective decision-making
- →Monitor and assess team performance, sharing learnings to drive consistency
- →Ensure smooth navigation of governance processes for deal progression
- →Work closely with S&E operations on external partnering events scheduling
Requirements
- ✓Proven experience in project management within a pharmaceutical or biotech environment
- ✓Strong understanding of research collaborations and licensing processes
- ✓Excellent leadership and cross-functional coordination skills
- ✓Ability to manage risks and drive effective decision-making
- ✓Experience with governance processes and deal progression
- ✓Strong communication and strategic thinking abilities
Free to sign up. Takes 30 seconds.
About Abbvie
Abbvie is a global biopharmaceutical company specializing in the research, development, and commercialization of innovative therapies. Headquartered in North Chicago, Illinois, the company was founded in 2013 following the spin-off of Abbott Laboratories' pharmaceutical division. Abbvie operates at the forefront of the biotechnology and pharmaceutical industries, focusing on addressing complex diseases and improving patient outcomes through scientific advancement. The company's primary products include treatments for immunology, oncology, and neurology, with its flagship drug, Humira, being one of the best-selling medications globally. Abbvie is known for its robust pipeline of investigational therapies, leveraging cutting-edge research and clinical trials to bring novel treatments to market. Its target audience includes patients, healthcare providers, and payers, with a particular emphasis on those suffering from chronic and life-threatening conditions. Key features of Abbvie's offerings include targeted therapies, personalized medicine approaches, and a commitment to regulatory compliance and safety. Abbvie has achieved significant milestones, including maintaining a leading position in the global pharmaceutical market and generating substantial revenue through its innovative portfolio. The company's unique value proposition lies in its dedication to scientific excellence and patient-centric care, supported by a strong pipeline and strategic investments in research and development. Abbvie's market position is further strengthened by its global reach, collaborative partnerships, and a reputation for delivering transformative therapies.
